Association between cardiometabolic index and hypertension among US adults from NHANES 1999–2020
In this study, we analyzed data from 45,250 participants from the National Health and Nutrition Examination Survey spanning 1999 to 2020. Using multivariable logistic regression, we explored the association between CMI and hypertension, employing Restricted Cubic Spline analysis to assess non-linear relationships and two-piecewise linear regression to identify threshold effects.
Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk
The pivotal role of nutrition interventions in the context of dyslipidemia and its cardiometabolic implications is discussed in this review, emphasizing evidence-based and personalized approaches.
Improving Therapeutic Adherence and Reducing Therapeutic Inertia in the Management of People with Cardiometabolic Diseases: A Call-to-Action from the Middle East
This article highlights these and other potential solutions for therapeutic non-adherence and inertia, as discussed at the 2024 Evidence in the Cardiometabolic Environment (EVIDENT) Summit.
Reducing the global prevalence of cardiometabolic risk factors: a bet worth winning
The importance of this has been emphasised once again by the Investigators of the Global Burden of Diseases (GBD), in the article published in this issue of Metabolism, showing that metabolic diseases continue to pose significant health challenges, although there are important differences in health burdens that have occurred over the last 30 years.
Unique cardiometabolic factors in women that contribute to modified cardiovascular disease risk
This review explores recent advancements in our understanding of CVD in women. We summarise the underlying factors unique to women that can promote CVD risk factors, ultimately contributing to CVD burden and the emerging therapies aimed to combat this.
Tackling cardiometabolic disease in southeast Asia: local research to inform local practice
With such a high burden of mortality, it is imperative that countries embrace innovative approaches to control the rising burden and strengthen health systems, in order to reduce the preventable mortality from these diseases.
The synergistic effect of obesity and dyslipidemia on hypertension: results from the STEPS survey
The aim of this study was to investigate the synergistic effect of general and central obesity with dyslipidemia on the risk of HTN.
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
This joint expert review by the Obesity Medicine Association (OMA) and National Lipid Association (NLA) provides clinicians an overview of the pathophysiologic and clinical considerations regarding obesity, dyslipidemia, and cardiovascular disease (CVD) risk.
Management of Hypertension in the Asia-Pacific Region: A Structured Review
This article reviews available evidence regarding hypertension management in the Asia-Pacific region, focussing on five research questions that deal with specific aspects: blood pressure (BP) control, guideline recommendations, role of renin–angiotensin–aldosterone system (RAAS) inhibitors in clinical practice, pharmacological management and real-world adherence to guideline recommendations.
Hypertension and Dyslipidemia: the Two Partners in Endothelium-Related Crime
The goal of this article is to characterize the endothelium’s role in the development of hypertension and dyslipidemia and to point out promising therapeutic directions.
Asia-Pacific Investigators and Asian Enrollment in Cardiometabolic Trials: Insights From Publications Between 2011 and 2020
This study aimed to assess the proportion and trends of Asian race participants and APAC authorship in cardiometabolic trials.
Asian Pacific Society of Cardiology Consensus Recommendations on Dyslipidaemia
The Asian Pacific Society of Cardiology (APSC) developed these consensus recommendations to address the need for a unified approach to managing dyslipidaemia. These recommendations are intended to guide general cardiologists and internists in the assessment and treatment of dyslipidaemia and are hoped to pave the way for improving screening, early diagnosis and treatment.
The Prevalence and Risk Factors of Hypertension among the Urban Population in Southeast Asian Countries: A Systematic Review and Meta-Analysis
A systematic review aiming to assess the prevalence of hypertension and its risk factors among the urban population in Southeast Asian countries was conducted. We performed database searches of PubMed and Web of Science and performed meta-analysis to determine the pooled prevalence estimate.
Dyslipidemia and Cardiometabolic Syndrome
The aim of this review is to highlight the fundamental aspects of the diagnostic criteria, pathophysiology, and the treatment of the dyslipidemia in cardiometabolic syndrome.
The 2017 Focused Update of the Guidelines of theTaiwan Society of Cardiology (TSOC) and theTaiwan Hypertension Society (THS) for theManagement of Hypertension
Based on the main findings from the Systolic Blood Pressure Intervention Trial (SPRINT) and several recent
meta-analyses, the HT committee members of the Taiwan Society of Cardiology and the Taiwan Hypertension Society convened and finalized the revised BP targets for management of HT. We suggested a new systolic BP target to < 120mmHg for patients with coronary heart disease, chronic kidney disease with an eGFR of 20-60 ml/min/1.73 m2, and elderly patients aged 75 years, using unattended automated office BP measurement.